{"acute respiratory distress syndrome": 12.45, "alanine aminotransferase increased": 2.07, "aspergillus infection": 149.2, "blood alkaline phosphatase increased": 7.54, "blood bilirubin increased": 5.6, "bronchopulmonary aspergillosis": 72.22, "candida infection": 39.66, "condition aggravated": 2.53, "cutaneous calcification": 1289.89, "death": 2.78, "disseminated intravascular coagulation": 7.6, "drug ineffective": 10.1, "drug ineffective for unapproved indication": 8.55, "drug interaction": 2.2, "drug resistance": 39.84, "drug-induced liver injury": 5.23, "febrile neutropenia": 2.56, "fungaemia": 225.37, "fungal infection": 30.14, "hepatic failure": 5.96, "hepatic function abnormal": 2.14, "hepatotoxicity": 11.73, "hypokalaemia": 3.56, "liver function test abnormal": 4.33, "mucormycosis": 169.28, "multiple organ dysfunction syndrome": 26.25, "pancytopenia": 2.56, "pathogen resistance": 87.99, "product use in unapproved indication": 3.39, "rash maculo-papular": 6.25, "renal failure": 3.18, "renal impairment": 2.47, "respiratory distress": 3.6, "respiratory failure": 5.82, "sepsis": 8.18, "septic shock": 18.48, "systemic candida": 176.35, "systemic mycosis": 95.24, "therapeutic product effect incomplete": 3.69, "therapy non-responder": 12.9, "toxic epidermal necrolysis": 9.82, "transaminases increased": 3.21, "treatment failure": 12.32}